Gilead Sciences emerges victorious in HIV drug patent lawsuit against US government.
Gilead Sciences has won a lawsuit filed by the US government over HIV drug patents. The government had claimed that Gilead failed to compensate the US Centers for Disease Control and Prevention (CDC) for discovering that its drug Truvada, which was first approved to treat HIV, could also help prevent infection by the virus. However, a federal jury found that Gilead did not infringe US patents with its HIV-prevention regimens using Truvada and Descovy, and that the government's patents were invalid and not infringed.
